Kessler Investment Group, LLC Gilead Sciences, Inc. Transaction History

Kessler Investment Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 15, 2018	SELL	$71.28 - $78.92 $832,978 - $922,259	-11,686 Closed	0 $0
Q2 2018 Jul 25, 2018	SELL	$64.88 - $75.68 $22,383 - $26,109	-345 Reduced 2.87%	11,686 $828,000
Q1 2018 Apr 13, 2018	SELL	$72.84 - $88.8 $88,354 - $107,714	-1,213 Reduced 9.16%	12,031 $907,000
Q4 2017 Jan 11, 2018	BUY	$71.15 - $83.52 $11,739 - $13,780	165 Added 1.26%	13,244 $949,000
Q3 2017 Oct 16, 2017	BUY	$72.11 - $85.47 $943,126 - $1.12 Million	13,079	13,079 $1.06 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Kessler Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Kessler Investment Group, LLC with notifications on news.